Search Results

<< Back to podcast list Strategic Partner(s) Dr. Daniel Wacker About Dr.

<< Back to podcast list Strategic Partner(s) Sri Kosuri About Dr.

< Back Your GPCR Order Has Arrived! Welcome back to your exclusive GPCR Weekly Newsletter! Come back regularly as we are adding courses each month.

. << Back to podcast list Strategic Partner(s) Jacob Lee and Jin Cho: Rebuilding the Software Layer Under They talk about the slow architecture of drug discovery, the compounding cost of irreproducibility, and different majors, different career paths, and a late-night message asking whether lab software could be hacked

<< Back to podcast list Strategic Partner(s) Dr. John Janetzko About Dr. The conversation emphasized the importance of diverse backgrounds and skill sets in tackling complex

<< Back to podcast list Strategic Partner(s) Dr. Françoise Bachelerie About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Caron Tribute Part 2 About Marc Caron Dr.

<< Back to podcast list Strategic Partner(s) Dr. Tobi Langenhan About Dr.

<< Back to podcast list Strategic Partner(s) Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat

<< Back to podcast list Strategic Partner(s) Dr. Adriano Marchese About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Sai Prasad Pydi About Dr. Sai Prasad Pydi Dr. along with different cell culture systems, to understand the role of immune cell GPCRs and their cross-talk

. << Back to podcast list Strategic Partner(s) Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila writing the first chapter - with no antibodies, no prior literature, and no established toolkit to fall back underdeveloped for fly receptors - Blanco-Redondo's group relies on CRISPR-introduced epitope tags to track "When I moved back from the US, I was not sure I wanted to continue in science.

<< Back to podcast list Strategic Partner(s) Dr. Rosie Dawaliby About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Robert F. Bruns About Dr. Robert F.

<< Back to podcast list Strategic Partner(s) Dr. Stephane Angers About Dr. Stephane Angers Dr.

<< Back to podcast list Strategic Partner(s) Dr. Caron Tribute Part 1 About Marc Caron Dr.

<< Back to podcast list Strategic Partner(s) Dr. Patrick Sexton About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Ralf Jockers About Dr.

. << Back to podcast list Strategic Partner(s) Dr. TRV-130 was denied FDA approval for lack of clear safety advantage.

. << Back to podcast list Strategic Partner(s) EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? which account for a large fraction of the receptor class — have been systematically sidestepped for lack

. << Back to podcast list Strategic Partner(s) Joseph Kim: Structural Biology and Drug Discovery at GPCRs The lack of potent small-molecule ligands continues to hinder research into these receptors. 6. I listened to one of his talks at a Gordon Conference and he was phenomenal. I remember distinctly sitting back one day and thinking: “Ah crud… I’m going to have to study GPCRs, I just looked it up while we were talking.

<< Back to podcast list Strategic Partner(s) Dr. Nariman Balenga About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Davide Calebiro About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Caron Tribute Part 3 About Marc Caron Dr.

<< Back to podcast list Strategic Partner(s) Dr. Sudarshan Rajagopal About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Raul Gainetdinov About Dr.

<< Back to podcast list Strategic Partner(s) Dr. Timo De Groof About Dr. Timo De Groof Dr.

<< Back to podcast list Strategic Partner(s) Dr. Stephen Ferguson About Dr. Stephen Ferguson Dr.

<< Back to podcast list Strategic Partner(s) Dr.

<< Back to podcast list Strategic Partner(s) Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche